Celltrion

Celltrion is a fully integrated biopharmaceutical company that develops, manufactures, and distributes innovative, cost‑effective medicines, with a particular focus on monoclonal antibody (mAb) biosimilars and next‑generation antibody‑based biologics. Leveraging end‑to‑end capabilities—from research and development through production and global distribution—Celltrion ensures high‑quality, affordable therapies that address unmet medical needs worldwide. The company’s value proposition centers on delivering advanced therapeutics to patients who previously had limited access, while fostering strategic partnerships that enhance customer intimacy across the care journey. Celltrion’s commitment to trust, efficiency, and continuous innovation makes it an attractive environment for professionals seeking to contribute to impactful health solutions.